Therapeutics Information for Providers

This page is for health care providers. Looking for treatment near you?

Providers: Add/Update Your Treatment Location

Latest Updates

Nov. 30

The U.S. Food and Drug Administration has announced bebtelovimab is not currently authorized for emergency use in the U.S. as of Nov. 30, 2022, because it is not expected to neutralize Omicron subvariants BQ.1 and BQ.1.1., according to data included in the Health Care Provider Fact Sheet. Eli Lilly and its authorized distributors have paused commercial distribution of bebtelovimab until further notice by the Agency. Additionally, ASPR has paused the fulfillment of any pending requests under its Bebtelovimab Product Replacement Initiative. NCDHHS will also pause the fulfillment of any pending requests under the NCDHHS Bebtelovimab Replacement Program. View the full FDA announcement here.

Nov. 7

NC Medicaid Optional COVID-19 (MCV) Testing, Treatment and Vaccination Program: Patients who are uninsured may be eligible to have their COVID-19 vaccine, testing, and treatment covered at no-cost by Medicaid, even if they are not currently a Medicaid beneficiary. NC Medicaid is reimbursing COVID-19 testing, treatment, and vaccination costs for individuals without insurance who enroll in the NC Medicaid Optional COVID-19 Testing, Treatment and Vaccination (MCV) program. To be eligible, an individual must:

  • Live in North Carolina.
  • Be a U.S. citizen or U.S. national or have eligible immigration status.
  • Not be covered by Medicaid, Medicare or other health insurance. 
  • Individuals may complete an application online. You may find additional information, including processing time for applications and a special bulletin about continued reimbursement for these services on the NC Medicaid website

View All Updates by Date

Product Summaries and Allocation Requests

Providers who want to receive allocations of new therapeutic products as they are released will need to register through NCDHHS and the federal portal following the instructions provided by NCDHHS.

Paxlovid Clinical Resources

More Provider Resources

Provider Office Hours

Join the NCDHHS COVID-19 Therapeutics Team for our monthly office hours (typically the second Friday of the month, at 12 p.m. ET) to discuss updates to and address questions related to all COVID-19 Therapeutics.

  • Join on Teams
  • Or call in (audio only): +1 984-204-1487 (Conference ID: 450 669 154#)

View Most Recent Office Hours Presentation

More Resources

Need Help?

Please submit all inquiries, issues, and feedback via the NCDHHS COVID-19 Testing and Treatment Inquiry Intake Form. For detailed instructions, please see the Testing and Treatment Inquiry Intake User Guide.

All Updates by Date

Have questions? We're here to help. 
Please submit all inquiries, issues, and feedback via the NCDHHS COVID-19 Testing and Treatment Inquiry Intake Form